Familial adenomatous polyposis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 11: Line 11:


===Prevalence===
===Prevalence===
*The prevalence of familial adenomatous polyposis is approximately 2.5-8.5 per 100,000 individuals in the Europe.
*The prevalence of familial adenomatous polyposis is approximately 3-10 per 100,000 individuals in the Europe.<ref name="HalfBercovich2009">{{cite journal|last1=Half|first1=Elizabeth|last2=Bercovich|first2=Dani|last3=Rozen|first3=Paul|title=Familial adenomatous polyposis|journal=Orphanet Journal of Rare Diseases|volume=4|issue=1|year=2009|pages=22|issn=1750-1172|doi=10.1186/1750-1172-4-22}}</ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
===Case-fatality rate/Mortality rate===
*In 1975, the incidence of familial adenomatous polyposis is approximately 13 per 100,000 individuals with a surgical mortality rate of 4.4% in Sweden.
*In 1975, the incidence of familial adenomatous polyposis is approximately 13 per 100,000 individuals with a surgical mortality rate of 4.4% in Sweden.<ref name="pmid">{{cite journal |vauthors=Alm T |title=Surgical treatment of hereditary adenomatosis of the colon and rectum in Sweden during the last 20 years. Part II. Patients with prophylactic operations, primary and late results. Discussion and summary |journal=Acta Chir Scand |volume=141 |issue=3 |pages=228–37 |year=1975 |pmid= |doi= |url=}}</ref>
 
===Age===
===Age===
*Patients of all age groups may develop [disease name].
*Patients in their first and second decades usually develop familial adenomatous polyposis.
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].
===Race===
===Race===
*There is no racial predilection to [disease name].
*There is no racial predilection to [disease name].

Revision as of 17:07, 26 January 2018

Familial adenomatous polyposis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Familial adenomatous polyposis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Familial adenomatous polyposis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Familial adenomatous polyposis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Familial adenomatous polyposis epidemiology and demographics

CDC on Familial adenomatous polyposis epidemiology and demographics

Familial adenomatous polyposis epidemiology and demographics in the news

Blogs on Familial adenomatous polyposis epidemiology and demographics

Directions to Hospitals Treating Familial adenomatous polyposis

Risk calculators and risk factors for Familial adenomatous polyposis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2], Mohamad Alkateb, MBBCh [3]

Overview

Epidemiology and Demographics

Incidence

  • The incidence familial adenomatous polyposis is approximately 12 per 100,000 births in the Europe.[1]

Prevalence

  • The prevalence of familial adenomatous polyposis is approximately 3-10 per 100,000 individuals in the Europe.[1]
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
  • The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

  • In 1975, the incidence of familial adenomatous polyposis is approximately 13 per 100,000 individuals with a surgical mortality rate of 4.4% in Sweden.[2]

Age

  • Patients in their first and second decades usually develop familial adenomatous polyposis.
  • The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.

Race

  • There is no racial predilection to [disease name].
  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

  • Familial adenomatous polyposis affects men and women equally.[1]

Region

  • Familial adenomatous polyposis is a rare disease that is worldwide.

References

  1. 1.0 1.1 1.2 Half, Elizabeth; Bercovich, Dani; Rozen, Paul (2009). "Familial adenomatous polyposis". Orphanet Journal of Rare Diseases. 4 (1): 22. doi:10.1186/1750-1172-4-22. ISSN 1750-1172.
  2. Alm T (1975). "Surgical treatment of hereditary adenomatosis of the colon and rectum in Sweden during the last 20 years. Part II. Patients with prophylactic operations, primary and late results. Discussion and summary". Acta Chir Scand. 141 (3): 228–37.